Method for improving the accuracy of quantitative cerebral perfusion imaging

Journal of Magnetic Resonance Imaging

Volumn 21, Issue 5, 2005, Pages 512-519

  Sakaie, Ken E ^a   Shin, Wanyong ^a   Curtin, Kenneth R ^b   McCarthy, Richard M ^b   Cashen, Ty A ^a   Carroll, Timothy J ^a,b,c  

^a Northwestern University   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Cerebral blood flow; Contrast enhanced; Magnetic resonance imaging; Perfusion; Stroke

Indexed keywords

ADULT; ARTICLE; BRAIN BLOOD FLOW; BRAIN BLOOD VOLUME; BRAIN PERFUSION; BRAIN SIZE; CALCULATION; CALIBRATION; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; ECHO PLANAR IMAGING; FEMALE; FUNCTIONAL ASSESSMENT; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REFERENCE VALUE; STATISTICAL SIGNIFICANCE; STEADY STATE; STROKE;

ADULT; BLOOD FLOW VELOCITY; BLOOD VOLUME DETERMINATION; BRAIN; CALIBRATION; CONTRAST MEDIA; FEMALE; GADOLINIUM DTPA; HUMANS; MAGNETIC RESONANCE IMAGING; MALE;

EID: 17844387165     PISSN: 10531807     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmri.20305     Document Type: Article

References (40)

1. del Zoppo GJ, Higashida RT, Furlan AJ, Pessin MS, Rowley HA, Gent M. PROACT: a phase II randomized trial of recombinant prourokinase by direct arterial delivery in acute middle cerebral artery stroke. PROACT Investigators. Prolyse in acute cerebral thromboembolism. Stroke 1998;29:4-11.
2. Combined intravenous and intra-arterial recanalization for acute ischemic stroke: the Interventional Management of Stroke Study. Stroke 2004;35:904-911.
3. National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995;333:1581-1587.
4. Chiu D, Krieger D, Villar-Cordova C, et al. Intravenous tissue plasminogen activator for acute ischemic stroke: feasibility, safety, and efficacy in the first year of clinical practice. Stroke 1998;29:18-22.
5. Katzan IL, Furlan AJ, Lloyd LE, et al. Use of tissue-type plasminogen activator for acute ischemic stroke: the Cleveland area experience. JAMA 2000;283:1151-1158.
6. Powers WJ, Grubb Jr RL, Darriet D, Raichle ME. Cerebral blood flow and cerebral metabolic rate of oxygen requirements for cerebral function and viability in humans. J Cereb Blood Flow Metab 1985;5:600-608.
7. Kaufmann AM, Firlik AD, Fukui MB, Wechsler LR, Jungries CA, Yonas H. Ischemic core and penumbra in human stroke. Stroke 1999;30:93-99.
8. Lin W, Lee JM, Lee YZ, Vo KD, Pilgram T, Hsu CY. Temporal relationship between apparent diffusion coefficient and absolute measurements of cerebral blood flow in acute stroke patients. Stroke 2003;34:64-70.
9. Rother J, Schellinger PD, Gass A, et al. Effect of intravenous thrombolysis on MRI parameters and functional outcome in acute stroke <6 hours. Stroke 2002;33:2438-2445.
10. Ueda T, Hatakeyama T, Kumon Y, Sakaki S, Uraoka T. Evaluation of risk of hemorrhagic transformation in local intra-arterial thrombolysis in acute ischemic stroke by initial SPECT. Stroke 1994;25: 298-303.
11. Rempp KA, Brix G, Wenz F, Becker CR, Guckel F, Lorenz WJ. Quantification of regional cerebral blood flow and volume with dynamic susceptibility contrast-enhanced MR imaging. Radiology 1994;193:637-641.
12. Lin W, Celik A, Derdeyn C, et al. Quantitative measurements of cerebral blood flow in patients with unilateral carotid artery occlusion: a PET and MR study. J Magn Reson Imaging 2001;14:659-667.
13. Ostergaard L, Johannsen P, Host-Poulsen P, et al. Cerebral blood flow measurements by magnetic resonance imaging bolus tracking: comparison with [(15)O]H2O positron emission tomography in humans. J Cereb Blood Flow Metab 1998;18:935-940.
14. Carroll TJ, Teneggi V, Jobin M, et al. Absolute quantification of cerebral blood flow with magnetic resonance, reproducibility of the method, and comparison with H2(15)O positron emission tomography. J Cereb Blood Flow Metab 2002;22:1149-1156.
15. van Osch MJ, Vonken EJ, Bakker CJ, Viergever MA. Correcting partial volume artifacts of the arterial input function in quantitative cerebral perfusion MRI. Magn Reson Med 2001;45:477-485.
16. Ellinger R, Kremser C, Schocke MF, et al. The impact of peak saturation of the arterial input function on quantitative evaluation of dynamic susceptibility contrast-enhanced MR studies. J Comput Assist Tomogr 2000;24:942-948.
17. Kiselev VG. On the theoretical basis of perfusion measurements by dynamic susceptibility contrast MRI. Magn Reson Med 2001;46: 1113-1122.
18. Kuppusamy K, Lin W, Cizek GR, Haacke EM. In vivo regional cerebral blood volume: quantitative assessment with 3D T1-weighted pre- and postcontrast MR imaging. Radiology 1996;201: 106-112.
19. Tudorica A, Fang Li H, Hospod F, et al. Cerebral blood volume measurements by rapid contrast infusion and T2*-weighted echo planar MRI. Magn Reson Med 2002;47:1145-1157.
20. Rosen BR, Belliveau JW, Vevea JM, Brady TJ. Perfusion imaging with NMR contrast agents. Magn Reson Med 1990;14:249-265.
21. Rosen BR, Belliveau JW, Buchbinder BR, et al. Contrast agents and cerebral hemodynamics. Magn Reson Med 1991;19:285-292.
22. Ostergaard L, Weisskoff RM, Chesler DA, Gyldensted C, Rosen BR. High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part I: mathematical approach and statistical analysis. Magn Reson Med 1996;36:715-725.
23. Hazlewood CF, Chang DC, Nichols BL, Woessner DE. Nuclear magnetic resonance transverse relaxation times of water protons in skeletal muscle. Biophys J 1974;14:583-606.
24. Carroll TJ, Haughton VM, Rowley HA, Cordes D. Confounding effect of large vessels on MR perfusion images analyzed with independent component analysis. AJNR Am J Neuroradiol 2002;23: 1007-1012.
25. Chung YCL, Laub G, Simonetti O.P. Inversion recovery cine True-FISP for optimizing T1 in myocardial infarct imaging. In: Proceedings of the 10th Annual Meeting of ISMRM, Honolulu, 2002. p 283.
26. Schmitt P, Griswold MA, Jakob PM, et al. Inversion recovery True-FISP: quantification of T(1), T(2), and spin density. Magn Reson Med 2004;51:661-667.
27. Zur Y, Stokar S, Bendel P. An analysis of fast Imaging sequences with steady-state transverse magnetization refocusing. Magn Reson Med 1988;6:175-193.
28. Haacke EM, Wielopolski PA, Tkach JA, Modic MT. Steady-state free recession imaging In the presence of motion: application for improved visualization of the cerebrospinal fluid. Radiology 1990; 175:545-552.
29. Ostergaard L, Sorensen AG, Kwong KK, Weisskoff RM, Gyldensted C, Rosen BR. High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part II: experimental comparison and preliminary results. Magn Reson Med 1996;36: 726-736.
30. Frackowiak RS, Lenzi GL, Jones T, Heather JD. Quantitative measurement of regional cerebral blood flow and oxygen metabolism in man using 15O and positron emission tomography: theory, procedure, and normal values. J Comput Assist Tomogr 1980;4:727-736.
31. Pantano P, Baron JC, Crouzel C, Collard P, Slrou P, Samson Y. The 15O continuous-inhalation method: correction for intravascular signal using C 15O. Eur J Nucl Med 1985;10:387-391.
32. Leenders KL, Perani D, Lammertsma AA, et al. Cerebral blood flow, blood volume and oxygen utilization. Normal values and effect of age. Brain 1990;113(Pt 1):27-47.
33. Hamberg LM, Hunter GJ, Kierstead D, Lo EH, Gilberto Gonzalez R, Wolf GL. Measurement of cerebral blood volume with subtraction three-dimensional functional CT. AJNR Am J Neuroradiol 1996;17: 1861-1869.
34. Newman GC, Delucia-Deranja E, Tudorica A, Hospod FE, Patlak CS. Cerebral blood volume measurements by T*2-weighted MRI and contrast infusion. Magn Reson Med 2003;50:844-855.
35. Calamante F, Gadian DG, Connelly A. Quantification of perfusion using bolus tracking magnetic resonance imaging in stroke: assumptions, limitations, and potential implications for clinical use. Stroke 2002;33:1146-1151.
36. Smith MR, Lu H, Trochet S, Frayne R. Removing the effect of SVD algorithmic artifacts present in quantitative MR perfusion studies. Magn Reson Med 2004;51:631-634.
37. Vonken EP, Beekman FJ, Bakker CJ, Viergever MA. Maximum likelihood estimation of cerebral blood flow in dynamic susceptibility contrast MRI. Magn Reson Med 1999;41:343-350,
38. Ostergaard L, Chesler DA, Weisskoff RM, Sorensen AG, Rosen BR. Modeling cerebral blood flow and flow heterogeneity from magnetic resonance residue data. J Cereb Blood Flow Metab 1999;19:690-699.
39. Wu O, Ostergaard L, Weisskoff RM, Benner T, Rosen BR, Sorensen AG. Tracer arrival timing-insensitive technique for estimating flow in MR perfusion-weighted imaging using singular value decomposition with a block-circulant deconvolutlon matrix. Magn Reson Med 2003;50:164-174.
40. Demsar F, Roberts TP, Schwickert HC, et al. A MRI spatial mapping technique for microvascular permeability and tissue blood volume based on macromolecular contrast agent distribution. Magn Reson Med 1997;37:236-242.